Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition

被引：0

作者：

Amy D Guertin

Melissa M Martin

Brian Roberts

Melissa Hurd

Xianlu Qu

Nathan R Miselis

Yaping Liu

Jing Li

Igor Feldman

Yair Benita

Andrew Bloecher

Carlo Toniatti

Stuart D Shumway

机构：

[1] Merck Research Laboratories,Department of Oncology

[2] Amgen,Department of In Vivo Pharmacology

[3] Hudson Alpha Institute,Molecular Biomarkers

[4] Merck Research Laboratories,Screening and Protein Sciences

[5] Merck Research Laboratories,Informatics and Analysis

[6] Merck Research Laboratories,undefined

[7] Merck Research Laboratories,undefined

[8] Institute for Applied Cancer Science,undefined

来源：

Cancer Cell International | / 12卷

关键词：

LoVo Cell; Sensitive Cell Line; Checkpoint Kinase; CHK1 Inhibitor; CHK1 Kinase;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
Wenxiu Qi
Chengzhi Xie
Chunhuai Li
J Timothy Caldwell
Holly Edwards
Jeffrey W Taub
Yue Wang
Hai Lin
Yubin Ge
Journal of Hematology & Oncology, 7
[42] EVALUATION OF BBB PERMEABLE WEE1 AND CHK1 INHIBITORS IN COMBINATION WITH STANDARD OF CARE FOR THE TREATMENT OF GLIOBLASTOMA
Scholefield, E. L.
Gomez-Roman, N.
NEURO-ONCOLOGY, 2024, 26 : V72 - V72
[43] Wee1 inhibition enhances the anti-tumor effects of capecitabine in preclinical models of triple negative breast cancer
Pitts, Todd M.
Simmons, Dennis M.
Dailey, Kyrie
Bagby, Stacey M.
Hartman, Sarah J.
Yacob, Betelehem W.
Gittleman, Brian
Tentler, John J.
Cittely, Diana
Ormond, D. Ryan
Messersmith, Wells A.
Eckhardt, S. Gail
Diamond, Jennifer R.
CANCER RESEARCH, 2020, 80 (04)
[44] A siRNA high-throughput screening identified Wee1 as determinant of Chk1 inhibitor sensitivity
Carrassa, Laura
Chila, Rosaria
Lupi, Monica
Ricci, Francesca
Mazzoletti, Marco
Celenza, Cinzia
Broggini, Massimo
Damia, Giovanna
CANCER RESEARCH, 2012, 72
[45] TARGETING CELL CYCLE S-PHASE STABILITY BY THE CONCOMITANT INHIBITION OF CHK1 AND WEE1 KINASES IN ACUTE LYMPHOBLASTIC LEUKEMIA
Luserna Di Rora, A. Ghelli
Ferrari, A.
Bocconcelli, M.
Imbrogno, E.
Robustelli, V.
Papayannidis, C.
Abbenante, M. C.
Marconi, G.
Nanni, J.
Parisi, S.
Sartor, C.
Paolini, S.
Cavo, M.
Martinelli, G.
HAEMATOLOGICA, 2018, 103 : S103 - S104
[46] Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
Lee, Yoo-Young
Cho, Young-Jae
Shin, Sung-won
Choi, Changhoon
Ryu, Ji-Yoon
Jeon, Hye-Kyung
Choi, Jung-Joo
Hwang, Jae Ryoung
Choi, Chel Hun
Kim, Tae-Joong
Kim, Byoung-Gie
Bae, Duk-Soo
Park, Won
Lee, Jeong-Won
SCIENTIFIC REPORTS, 2019, 9 (1)
[47] Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
Yoo-Young Lee
Young-Jae Cho
Sung-won Shin
Changhoon Choi
Ji-Yoon Ryu
Hye-Kyung Jeon
Jung-Joo Choi
Jae Ryoung Hwang
Chel Hun Choi
Tae-Joong Kim
Byoung- Gie Kim
Duk-Soo Bae
Won Park
Jeong-Won Lee
Scientific Reports, 9
[48] Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication
Sorensen, Claus Storgaard
Syljuasen, Randi G.
NUCLEIC ACIDS RESEARCH, 2012, 40 (02) : 477 - 486
[49] ING2 loss sensitizes KRAS-mutated NSCLC to WEE1 inhibition through regulation of CHK1 expression.
Ricordel, Charles
Thalappilly, Subash
Archambeau, Jerome
Chan, Angela
Nixon, Nancy
Desrues, Benoit
Bebb, Gwyn
Riabowol, Karl
Pedeux, Remy
MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 57 - 57
[50] Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
Pitts, Todd M.
Simmons, Dennis M.
Bagby, Stacey M.
Hartman, Sarah J.
Yacob, Betelehem W.
Gittleman, Brian
Tentler, John J.
Cittelly, Diana
Ormond, D. Ryan
Messersmith, Wells A.
Eckhardt, S. Gail
Diamond, Jennifer R.
CANCERS, 2020, 12 (03)

← 1 2 3 4 5 →